H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| BAYER U.S. LLC | 5 | $118,000 | $110,000 - $128,742 | 100.0% |
| Eli Lilly and Company | 2 | $130,250 | $127,500 - $133,000 | 50.0% |
| ABBVIE BIORESEARCH CENTER | 1 | $122,306 | $122,306 - $122,306 | 100.0% |
| BAYER HEALTHCARE | 1 | $136,117 | $136,117 - $136,117 | 100.0% |
| Cerevel Therapeutics, LLC | 1 | $120,119 | $120,119 - $120,119 | 100.0% |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Morristown | NJ | 6 | $121,500 |
| Cambridge | MA | 3 | $122,306 |
| Indianapolis | IN | 1 | $127,500 |
These roles are variations of Research Scientist Formulation Development with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Research Scientist Formulation Development | Unspecified | 15 | $109,488 |
| RESEARCH SCIENTIST (FORMULATIONS DEVELOPMENT) | Unspecified | 1 | $106,502 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 1 | $127,500 | 100.0% |
| 2022 | 3 | $118,000 | 100.0% |
| 2023 | 2 | $121,500 | 50.0% |
| 2024 | 1 | $120,119 | 100.0% |
| 2025 | 3 | $128,742 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| BAYER U.S. LLC | 5 | $118,000 | 100.0% |
| Eli Lilly and Company | 2 | $130,250 | 50.0% |
| ABBVIE BIORESEARCH CENTER | 1 | $122,306 | 100.0% |
| BAYER HEALTHCARE | 1 | $136,117 | 100.0% |
| Cerevel Therapeutics, LLC | 1 | $120,119 | 100.0% |